| P50 | author | irfan nuhoglu | Q58273018 |
| | Mustafa Kocak | Q79718093 |
| P2093 | author name string | Mustafa Yilmaz | |
| | Cihangir Erem | |
| | Halil Onder Ersoz | |
| | Ozge Ucuncu | |
| P2860 | cites work | Plasma carboxypeptidases as regulators of the plasminogen system | Q24677226 |
| | Tissue factor pathway inhibitor: structure, biology and involvement in disease | Q28279765 |
| | Plasma thrombin activatable fibrinolysis inhibitor and tissue factor pathway inhibitor changes following sepsis | Q28565750 |
| | Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism | Q31831306 |
| | Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease | Q31898591 |
| | Thyroid, hemostasis and thrombosis | Q33365293 |
| | Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura. | Q33489614 |
| | Coagulation disorders in thyroid diseases | Q33498490 |
| | Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor | Q34059019 |
| | Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine | Q34211602 |
| | Coagulopathies and arterial stroke | Q35077520 |
| | Hemostasis and thyroid diseases revisited | Q36008326 |
| | The anticoagulant protein C pathway | Q36156027 |
| | Assessment of hemostatic risk factors in predicting arterial thrombotic events | Q36229247 |
| | The role of tissue factor pathway inhibitor in a revised coagulation cascade | Q36370143 |
| | Hemostatic changes in thyroid diseases: haemostasis and thrombosis | Q36746455 |
| | Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review | Q36794153 |
| | Hypothyroidism: diversity of presentation | Q40184509 |
| | Plasma levels of adiponectin and soluble thrombomodulin in hypothyroid patients with normal thyroid function following levothyroxine replacement therapy | Q42484836 |
| | Factor-VII activity and ischaemic heart disease: fatal and non-fatal events. | Q43987629 |
| | Blood coagulation and fibrinolytic activity in hypothyroidism | Q44379895 |
| | Coagulation factor VII and the risk of coronary heart disease in healthy men. | Q45023956 |
| | Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism | Q46367596 |
| | Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity | Q46951308 |
| | Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism | Q47247982 |
| | Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke. | Q48181694 |
| | Thrombin-activable fibrinolysis inhibitor levels in the acute phase of ischemic stroke. | Q48358676 |
| | Plasma thrombin-activatable fibrinolytic inhibitor (TAFI) among healthy subjects and patients with vascular diseases: a validation study | Q49080002 |
| | Relationship between thyroid hormones and plasma D-dimer levels. | Q50909245 |
| | Thrombin-activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis. | Q51790480 |
| | Fibrinogen, factor VII clotting activity and coronary artery disease severity | Q67255139 |
| | Is a hypercoagulable state present in hypothyroidism? | Q68024180 |
| | Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study | Q69886150 |
| | Hypothyroidism as a cause of acquired von Willebrand's disease | Q69898280 |
| | Hypothyroidism and von Willebrand's disease | Q69899928 |
| | Decreased plasma tissue factor pathway inhibitor activity in ischemic stroke patients | Q70897387 |
| | Primary haemostasis in thyroid disease | Q71700941 |
| | Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Graves' disease: TM, a possible new marker of the peripheral activity of thyroid hormones | Q72072221 |
| | Plasma procarboxypeptidase U in men with symptomatic coronary artery disease | Q73043894 |
| | [Study of serum thrombomodulin(TM) levels in patients with hyper- or hypo- thyroidism] | Q73044029 |
| | Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis | Q73708466 |
| | Blood coagulation | Q73814629 |
| | Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe | Q74079222 |
| | Blood coagulation and fibrinolysis in patients with hyperthyroidism | Q74177189 |
| | Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives | Q74595117 |
| | Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography | Q78800602 |
| | Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders | Q79086347 |
| | Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacement | Q79337660 |
| | Altered platelet plug formation in hyperthyroidism and hypothyroidism | Q80293212 |
| | Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level | Q80348911 |
| | High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke | Q81041511 |
| | Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism | Q81443631 |
| | Haemostatic function in subjects with mild subclinical hypothyroidism. The Tromsø study | Q83120444 |
| P433 | issue | 1 | |
| P304 | page(s) | 75-80 | |
| P577 | publication date | 2008-10-29 | |
| P1433 | published in | Endocrine | Q15757048 |
| P1476 | title | Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism | |
| P478 | volume | 35 | |